Revenue Growth YoY (Last 12 Months): Smith+Nephew (SNN)

Brandmark of Smith+Nephew (SNN)

Stable diversification of raw material streams and precise inventory accounting have ensured uninterrupted supplies for Smith & Nephew plc (SNN). The current year-over-year sales trend over 12 months captures revenue dynamics, where the parameter value reaches 5.30. High margins are supported by the scaling of patented implants, while ultimate success relies on the recovery of surgical volumes and overcoming pricing pressure in China.

Smith+Nephew (SNN) Sales Growth YoY (TTM): for the period 02/11/2024 - 11/18/2026

Smith & Nephew PLC (SNN) - metric breakdowns and financial figures

- company stock exchange capitalization indicators:
Summary company analytics:SNN (Smith+Nephew)
Signature product of Smith & Nephew

The selection of high-quality issuers is based on revenue stability, where the annual change in sales volume over the LTM allows for the filtering of short-term noise and an assessment of real revenue dynamics over a rolling year. For Smith & Nephew plc (SNN), this indicator confirms business resilience driven by the implementation of orthopedic robotics and sports medicine, helping investors identify the growth phase before the potential of new biomaterials is fully realized.